Qube Research & Technologies Ltd - BELITE BIO INC ownership

Back to all holdings Add to watchlist

BELITE BIO INC's ticker is and the CUSIP is 07782B104. A total of 7 filers reported holding BELITE BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of BELITE BIO INC
ValueSharesWeighting
Q3 2023$16,587
-92.4%
525
-93.0%
0.00%
-100.0%
Q1 2023$218,538
-32.8%
7,528
-29.1%
0.00%
-50.0%
Q4 2022$325,003
-7.9%
10,621
+1.7%
0.00%0.0%
Q3 2022$353,000
+70.5%
10,442
+57.3%
0.00%0.0%
Q2 2022$207,000–6,640–0.00%–
 Download
Other shareholders
BELITE BIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 148,000$6,760,6400.08%
Virtus ETF Advisers LLC 1,807$82,5440.04%
GAMMA Investing LLC 428$19,5510.00%
HRT FINANCIAL LP 5,409$2470.00%
Point72 Asset Management, L.P. 7,311$333,9660.00%
JPMORGAN CHASE & CO 88$4,0200.00%
MORGAN STANLEY 1,044$47,6900.00%
STATE STREET CORP 15,671$715,8510.00%
BANK OF AMERICA CORP /DE/ 102$4,6590.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BELITE BIO INC shareholders